Author Archives: Linxuan Yan

STLR Link Roundup – March 15, 2019

Posted on by

The Apple-Qualcomm Patent Battle On March 15, 2019, the jury of the federal District Court for the Southern District of California found that Apple infringed on three patents of Qualcomm and was required to compensate Qualcomm $1.41 per infringing iPhone sold. Specifically, the court found that Apple’s iPhone 7, 7 Plus, 8, 8 Plus and X have infringed Qualcomm’s two U.S. patents, 8,838,949 and 9,535,490. Also, Apple’s iPhone 8, 8 Plus and X have infringed Continue Reading →

Has a Federal Circuit Decision Ended the CRIPSR/Cas Patent Battle?

Posted on by

On September 10, 2018, the U.S. Court of Appeals for the Federal Circuit’s decision in Regents of the University of California v. Broad Institute, Inc. may have ended perhaps the most heated biotech patent battle today: who owns the fundamental patents for the powerful CRISPR/Cas gene-editing tool. Unless University of California, Berkeley (UCB) successfully appeals the decision to the U.S. Supreme Court, the Broad Institute will keep its patents on CRISPR/Cas technology.   History of Continue Reading →